COVID 19 Management

Hetero Healthcare has launched three antiviral medicines in one year to fight Corona with a determination to contribute to the vision "COVID-free India."
These antiviral medicines act as Corona warriors and have proved efficacy in treating the virus. At a stage when the cases reached the skies, the availability of the medicine became instinct. Our robust antivirals broke the chain and catered to the increasing demand treating people who were hospitalized due to a severe attack of the breath-taking virus and aided in reducing the impact of the life-threatening pandemic.

Our antiviral medicines include:
Covifor- Remdesivir is a broad-spectrum antiviral injection that supports the health of the respiratory system of Corona-affected patients.
Favivir- Favipiravir is used to treat Covid 19 as it shows high standards of care and fosters quick results.
Barcy- Baricitinib, Baricitinib in combination with Remdesivir is indicated for treatment of suspected or laboratory confirmed COVID-19 in hospitalized adults and pediatric patients 2 years of age or older requiring supplemental oxygen, invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO).

Our Therapies

COVID 19 Management

Our innovative antiviral medications are highly approved to treat COVID -19, produce benignant care for the complications, and abort the progression of the risk factors that leads to severe illness.